Bayer seals Roche deal
This article was originally published in The Tan Sheet
Executive Summary
Roche Consumer Health becomes part of Bayer's Consumer Care Division following the Dec. 31 close of a deal first announced in July (1"The Tan Sheet" July 26, 2004, p. 3). The merger places Bayer in the world's top three OTC consumer health organizations, Bayer says. "The combination of the two organizations results in a commercial entity that is more successful than the sum of its parts," Bayer Consumer Care President Gary Balkema said...
You may also be interested in...
Bayer/Roche Consumer Unit Will Focus On Rx-To-OTC Switch Opportunities
Bayer expects the addition of Roche Consumer Health to bolster the firm's ability to handle future Rx-to-OTC switches
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.